Blood-brain barrier (BBB) disruption underlies the origin of many brain disorders. Measuring subtle BBB leakage of gadolinium-based contrast agents is commonly performed by a continuous and time-consuming dynamic MRI protocol. However, BBB leakage is subtle, for which discrete sampling at strategic time-points might be sufficient. This study explores the feasibility of the time-efficient interleaved protocol by applying it to brain tumor patients. We were able to measure high permeability in a craniopharyngioma and low permeability in a low-grade tumor and in healthy tissue. The time-efficient protocol is promising and will be further evaluated in more patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords